PainTx Challenge was developed by Clinical Tools, Inc (CTI) with funding from the National Institute of Drug Abuse (#1R44DA035042). We gratefully acknowledge this support, which was the sole funding source for this project’s development.
An epidemic of addiction to prescription pain medications now causes deaths due to overdose that outnumber automobile-related deaths, rising admissions to hospitals, and disrupted lives for both the patient and family.
PainTx Challenge has developed a collection of didactic training modules and interactive patient case experiences to help providers enhance their clinical skills and test practice change through deliberate practice via simulated (i.e., computer-generated) patients.
Continuing Education Mission Statement
Clinical Tools, Inc. combines medicine, science, and technology to provide state-of-the-art online and training and education to improve patient care.
We strive to enhance the knowledge, skills, and practice of health care providers and trainees so they can improve patient health. Our standard incorporates the most up-to-date research and expert opinion. The company identifies content areas that are under-represented in current CME curricula, are skills-oriented and would benefit from internet delivery – including innovative uses of emerging technology.
Activity content is determined by analysis of gaps in performance, knowledge and competence, and patient outcomes, including national guidelines, best practices reports, user surveys, literature review, and consultations with experts. Our focus is on creating clinical skills-based training activities and evaluating each activity using metrics that relate to the targeted skills. Successful activities will improve competence, performance, skills, use of best practices, and patient outcomes. The impact is evaluated using both qualitative and quantitative methods to assure quality and to measure competence, skills, and behaviors essential to providing quality patient care and improving outcomes.
Clinical Tools does not participate in the delivery of complete and finalized training experiences. Nor do we participate when decisions have already been made regarding the practice gaps, content, delivery, authorship, or the assessment of the intervention. We only provide Category I CME (TM) for an activity when we are closely involved in meeting all of the ACCME requirements, including the collection, storage, and analysis of data on the impact of the activity on competence, performance, or patient outcomes.
No Industry Support
All materials on this website were developed in an industry-fund-free environment. No industry funding was used to create this website or these educational activities.
PainTx Challenge will not only help providers enhance their clinical skills and test practice change, but also allow clinic leaders and health care organizations to implement a comprehensive continuing health professional development (CHPD) program.
Clinical Tools, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Clinical Tools, Inc. is an NBCC-Approved Continuing Education Provider (ACEPTM) and may offer NBCC-approved clock hours for events that meet NBCC requirements. The ACEP solely is responsible for all aspects of the activity.
Clinical Tools, and its gaming division Health Impact Studio, strives to share knowledge gained through the testing and use of its products. You can see our latest conference presentations, as well as our published research articles, at the Health Impact Studio site.
We will continue expanding our PainTx Challenge curriculum to include further topics regarding pain treatment and opioid use. We envision that our bundled activities will be sold as a training tool for medical provider groups / offices in order to provide consistent and up-to-date education on this topic. This source of revenue will support any ongoing work needed to refine the product and allow consistent group training for these providers.
Thank you to the numerous individuals who participated in the project’s formative stage development, and to those who send us comments and feedback about the site.